Safety, PK and PD of FLQ-101 in Premature Neonates

Recruiting now · Phase 1

Conditions studied: Retinopathy of Prematurity (ROP)

In brief

The purpose of this study is to evaluate safety and efficacy outcomes following exposure to FLQ-101.

Key facts

Study ID
NCT07093255
Run by
FELIQS INC.
People needed
18
Starts
2026-04-03
Expected to finish
2026-12-31
Last updated by the study team
2026-04-21

Who can join

Age: 0 and older, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.